← Leaderboards
Sidney M. Hecht
University Of Virginia
$9,031,231
Attributed
$9,031,231
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $777.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,031,231 · 7
By mechanism
R01$6,256,297 · 5
R35$2,409,950 · 1
R21$364,984 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogPropertyAmino AcidsProteinsBiochemicalMediatingDesignModificationStructurePositioning AttributeSiteDipeptidesRibosomesIn VitroPreparationNucleic AcidsAffinityBindingBiologicalExhibitsBaseLaboratoriesCellsRna, Ribosomal, 23s
Grant awards (32)
Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins$518,100
R35 · FY2025 · GM · contact PI
Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins$518,100
R35 · FY2024 · GM · contact PI
Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins$518,100
R35 · FY2023 · GM · contact PI
Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins$518,100
R35 · FY2022 · GM · contact PI
Biological Regulation Studied In Vitro and In Cellulo with Modified Proteins$337,550
R35 · FY2021 · GM · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$266,900
R01 · FY2021 · GM · contact PI
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides$293,550
R01 · FY2020 · GM · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$266,900
R01 · FY2020 · GM · contact PI
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides$293,550
R01 · FY2019 · GM · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$266,404
R01 · FY2019 · GM · contact PI
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides$293,550
R01 · FY2018 · GM · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$265,555
R01 · FY2018 · GM · contact PI
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides$75,000
R01 · FY2018 · GM · contact PI
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides$293,550
R01 · FY2017 · GM · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$193,132
R01 · FY2015 · GM · contact PI
Molecular Recognition by Bleomycin$297,737
R01 · FY2014 · CA · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$193,704
R01 · FY2014 · GM · contact PI
Dynamic Properties that Enhance Enzyme Function$300,974
R01 · FY2013 · GM · contact PI
Molecular Recognition by Bleomycin$288,529
R01 · FY2013 · CA · contact PI
Selection of Modified Ribosomes Using Novel Puromycins$188,438
R01 · FY2013 · GM · contact PI
Dynamic Properties that Enhance Enzyme Function$311,890
R01 · FY2012 · GM · contact PI
Molecular Recognition by Bleomycin$306,945
R01 · FY2012 · CA · contact PI
Dynamic Properties that Enhance Enzyme Function$311,890
R01 · FY2011 · GM · contact PI
Molecular Recognition by Bleomycin$306,945
R01 · FY2011 · CA · contact PI
Dynamic Properties that Enhance Enzyme Function$328,165
R01 · FY2010 · GM · contact PI
Molecular Recognition by Bleomycin$316,438
R01 · FY2010 · CA · contact PI
Inhibitors of p90Rsk$182,407
R01 · FY2009 · CA · contact PI
Inhibitors of p90Rsk$122,222
R01 · FY2008 · CA · contact PI
Inhibitors of p90Rsk$79,822
R01 · FY2008 · CA · contact PI
Inhibitors of p90Rsk$212,100
R01 · FY2007 · CA · contact PI
Novel Tools for the Study of HIV-1 RNase H Inhibition$157,484
R21 · FY2007 · AI · contact PI
Novel Tools for the Study of HIV-1 RNase H Inhibition$207,500
R21 · FY2006 · AI · contact PI